Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upfront Sunitinib (SU011248) Therapy Followed by Surgery in Patients With Metastatic Renal Cancer: A Pilot Phase II Study [SuMR]

NCT01024205 is registered in ClinicalTrials.gov with Barts and the London School of Medicine and Dentistry as lead sponsor.

NCT NCT01024205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01024205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upfront Sunitinib (SU011248) Therapy Followed by Surgery in Patients With Metastatic Renal Cancer: A Pilot Phase II Study [SuMR]
Lead sponsor
Barts and the London School of Medicine and Dentistry
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
May 31, 2012
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer